Health CanadaType I
Inderal-LA: Nitrosamine Impurity
Published: March 2, 2022Recall ID: 63959Category: generalCountry: Canada
Reason for Recall / Hazard
Contamination
Product Description & Identification
Contact your health care provider to discuss other treatment options, as there are no other companies marketing extended release propranolol in Canada.Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition poses a greater health risk.Contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries and at 1-800-387-4974 for general inquiries if you have questions about the recall.Report any health product-related side effects or complaints to Health Canada.
Affected Products
Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths
Additional Source Details
| Field | Value |
|---|---|
| N I D | 63959 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/inderal-nitrosamine-impurity |
| Issue | Contamination |
| Title | Inderal-LA: Nitrosamine Impurity |
| Product | Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-03-02 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Contact your health care provider to discuss other treatment options, as there are no other companies marketing extended release propranolol in Canada.Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition poses a greater health risk.Contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries and at 1-800-387-4974 for general inquiries if you have questions about the recall.Report any health product-related side effects or complaints to Health Canada. |